Academic Journal
Q3Gynecologic Oncology Reports
About Gynecologic Oncology Reports
Gynecologic Oncology Reports is a scholarly journal published by Elsevier B.V.. SCImago 2025 lists it in Q3, with an SJR of 0.457 and H-index of 32.
Coverage: 2014-2026. Research categories: Obstetrics and Gynecology (Q3); Oncology (Q3).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Endometrial and Cervical Cancer Treatments; Ovarian cancer diagnosis and treatment; Uterine Myomas and Treatments; Cervical Cancer and HPV Research; Sarcoma Diagnosis and Treatment; Intraperitoneal and Appendiceal Malignancies.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Abscopal effect following palliative radiotherapy after cemiplimab in recurrent cervical cancer: a case report
Chihiro Mano, Michihiro Tanikawa, Misako Kusakabe, Reiko Nakamura et al.
2026-10 · DOI: 10.1016/j.gore.2026.102207Analytical and clinical validation of the EdenDx methylation assay as a noninvasive supportive triage tool for early detection of endometrial cancer in cervical scraping specimens
Rojeet Shrestha, Bo-Ram Bang, Safedin Beqaj
2026-10 · DOI: 10.1016/j.gore.2026.102221Molecular subtypes of stage III vulvar squamous cell carcinoma predict recurrence and survival outcomes
Simrit K. Warring, Mark R. Hopkins, Michaela E. McGree, Evdokiya E. Knyazhanskaya et al.
2026-10 · DOI: 10.1016/j.gore.2026.102192Paclitaxel hypersensitivity reaction rates in gynecologic and medical oncology patients following slow titration protocol: A quality improvement project
Riley Miller, Allison R. Walker, Dereje Negatu, Jenna Synnamon et al.
2026-10 · DOI: 10.1016/j.gore.2026.102212Enhancing patient understanding of ovarian cancer: creation, validation and user-readability evaluation of an education booklet
Sabith Ahmed, Allen Pinto, Sheavon Serrao, T. Krishna Sharan et al.
2026-10 · DOI: 10.1016/j.gore.2026.102220Apparent diffusion coefficient values on MRI as biomarkers for pre operative prediction of prognostic factors in endometrial cancer
Ashika Padival, Bijal Manish Patel, Chetana D. Parekh, Ruchi Arora et al.
2026-10 · DOI: 10.1016/j.gore.2026.102218Temozolomide and olaparib for the treatment of an ARID1A-mutated uterine carcinosarcoma: A case report
Chrissy Liu, Yasmin Abozenah, Thomas J. Rutherford, Vaagn Andikyan et al.
2026-10 · DOI: 10.1016/j.gore.2026.102210Stevens-Johnson syndrome precipitating days after treatment for dostarlimab-induced autoimmune encephalitis: a case report
Morgan Kuchar, Akash Shah, Rayyan Khan, Taylor Pigg et al.
2026-10 · DOI: 10.1016/j.gore.2026.102219Advances in uterine sarcoma management: A mini-review of clinical practice and molecular insights
Grace M. Lee, Fiorella Reyes-Baez, Jhalak Dholakia
2026-10 · DOI: 10.1016/j.gore.2026.102217HER2-directed therapy with Trastuzumab deruxtecan in recurrent mucinous ovarian carcinoma: complete clinical response and response to rechallenge
Oriana Krivenko, Nicole Diaz, Jenna Marcus, Fernanda Musa et al.
2026-10 · DOI: 10.1016/j.gore.2026.102205Fertility-sparing surgery for a patient with a pre-operative suspected diagnosis of a Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A case report
Matthew P. Kipp, Zoe A. Roecker, Azin Mashayekhi, Jennifer M. Scalici et al.
2026-10 · DOI: 10.1016/j.gore.2026.102206Serous borderline tumor progressing to low-grade serous carcinoma after 35 years: a case of extended latency with molecular evidence of clonal relationship
Emily A. Towery, Elizabeth H. Stover, David L. Kolin, Rebecca L. Porter et al.
2026-10 · DOI: 10.1016/j.gore.2026.102194An atypical presentation of Pembrolizumab-induced bullous pemphigoid in a patient with uterine serous carcinoma
Rachel Y. Chen, Chirag Vasavda, Sotonye Imadojemu, Stephanie W. Liu et al.
2026-10 · DOI: 10.1016/j.gore.2026.102188Response to Sotorasib in a patient with recurrent KRAS G12C-mutated low-grade serous ovarian cancer: a case report and literature review
Erin Hickey Zacholski, Wen Jing Liu, Ryan Clayton, Jaclyn Wall et al.
2026-10 · DOI: 10.1016/j.gore.2026.102203Atypical placental site nodules: A Clinicopathologic study of 11 cases at an urban academic institution
Grace Y. Lee, Austin Chan, Cyrus M. Jalai, Fnu Sapna et al.
2026-10 · DOI: 10.1016/j.gore.2026.102202Pediatric lynch-associated melanoma arising in ovarian teratoma: a case report
Rana Alcheikh, Jaime O. Boyd, Shahrazad Saab, Pedro Albuquerque et al.
2026-10 · DOI: 10.1016/j.gore.2026.102226Myotonic dystrophy type 1 as a cancer predisposition syndrome: A case report of quadruple primary malignancies with review of the literature
Koya Fujiyama, Mariko Nakahara, Yosuke Ito, Hiroki Yamada et al.
2026-10 · DOI: 10.1016/j.gore.2026.102228Docetaxel for recurrent adult granulosa cell tumor enabling tertiary cytoreduction
Maryam Ali, Katherine Jane C. Chua, Hui Chen
2026-10 · DOI: 10.1016/j.gore.2026.102216Assessing social determinants of health needs in newly diagnosed gynecologic oncology patients and their relationship with social support and stress levels
Rose Karvandi, Jennifer Jorgensen, Jeffrey E. Pella
2026-10 · DOI: 10.1016/j.gore.2026.102211AfroSHARE Summit: visions of health equity for black women with gynecologic and breast cancers
Nefa-Tari Moore, Megan-Claire Chase, Christine Benjamin, Stephanie Poland et al.
2026-10 · DOI: 10.1016/j.gore.2026.102208Reviews
Community Reviews
Version History
October 4, 2026 at 9:21 pm
October 2, 2026